Can you tell the difference between an advertising claim and research-backed statistics? For chronic disease patients who take supplements to manage their conditions, this is an ongoing problem. And the Food and Drug Administration can’t always keep up with new products, claims, and supplements.
ChromaDex CEO Robert Fried explains what patients should look for in a company when researching supplements. And how clinical research is unlocking their potential uses for rare and chronic diseases. Also, Kate speaks with Kayla Smock on insurance hurdles facing Occipital Neuralgia patients and why the condition is so much more than just a headache.
Hosts:
Terry Wilcox, Executive Director, Patients Rising
Dr. Robert Goldberg, “Dr. Bob,” Co-Founder and Vice President of the Center for Medicine in the Public Interest
Kate Pecora, Field Correspondent
Guests:
Robert Fried, CEO, ChromaDex
Kayla Smock, President and Founder, Occipital Neuralgia Foundation
Ronetta Stokes, Patient Correspondent
Links:
Drugmakers sue HHS over Medicaid drug rebate rule
Improving Seniors’ Timely Access to Care Act of 2021
Patients Rising Survey: Occipital Neuralgia: A New Look at Patient Experiences
Need help?
The successful patient is one who can get what they need when they need it. We all know insurance slows us down, so why not take matters into your own hands. Our Navigator is an online tool that allows you to search a massive network of health-related resources using your zip code so you get local results. Get proactive and become a more successful patient right now at PatientsRisingConcierge.org
Have a question or comment about the show, want to suggest a show topic or share your story as a patient correspondent?
Drop us a line: podcast@patientsrising.org
The views and opinions expressed herein are those of the guest(s)/ author(s) and do not reflect the official policy or position of Patients Rising.